Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The update appears to be a site-wide revision tag with no changes to the study content or displayed details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:51:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page no longer displays the government funding operating-status notice. All study details, eligibility criteria, locations, and outcomes remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T17:30:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study record now shows termination with the note 'Terminated Trial failed to meet primary endpoint' and the Last Update Posted date updated to 2024-07-29.
    Difference
    0.3%
    Check dated 2025-11-03T09:52:59.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Updates present: a status notice about funding-related delays and open NIH Clinical Center with links for more details, and a version bump to v3.2.0. This shifts core information and versioning; no other functional changes are evident.
    Difference
    4%
    Check dated 2025-10-05T14:28:55.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.
    Difference
    0.4%
    Check dated 2025-09-28T09:46:35.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2, and the 'Back to Top' control was removed. No changes to core content, pricing, stock availability, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T00:18:30.000Z thumbnail image

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.